These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7422102)
1. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--III. The effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses. Green AR; Costain DW; Deakin JF Neuropharmacology; 1980 Sep; 19(9):907-14. PubMed ID: 7422102 [No Abstract] [Full Text] [Related]
2. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock. Cowen PJ; Nutt DJ; Green AR Neuropharmacology; 1980 Sep; 19(9):901-6. PubMed ID: 7422101 [No Abstract] [Full Text] [Related]
3. Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock. Mason ST; Corcoran ME J Pharm Pharmacol; 1979 Apr; 31(4):209-11. PubMed ID: 36457 [TBL] [Abstract][Full Text] [Related]
4. Responses of developing rats to L-tryptophan plus an maoi-II. Effects of repeated electroconvulsive shock. Atterwill CK; Green AR Neuropharmacology; 1980 Apr; 19(4):337-41. PubMed ID: 7189832 [No Abstract] [Full Text] [Related]
5. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine. Green AR; Mitchell BD; Tordoff AF; Youdim MB Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205 [No Abstract] [Full Text] [Related]
6. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--I. The effects of single and repeated bicuculline-induced seizures. Nutt DJ; Green AR; Grahame-Smith DG Neuropharmacology; 1980 Sep; 19(9):897-900. PubMed ID: 7422100 [No Abstract] [Full Text] [Related]
7. The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats. Bhavsar VH; Dhumal VR; Kelkar VV Eur J Pharmacol; 1981 Sep; 74(2-3):243-7. PubMed ID: 7327204 [TBL] [Abstract][Full Text] [Related]
8. Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour. Green AR; Deakin JF Nature; 1980 May; 285(5762):232-3. PubMed ID: 7374776 [TBL] [Abstract][Full Text] [Related]
9. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine. Green AR; Heal DJ; Grahame-Smith DG Psychopharmacology (Berl); 1977 Apr; 52(2):195-200. PubMed ID: 196304 [No Abstract] [Full Text] [Related]
10. Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses. Green AR Br J Pharmacol; 1978 Mar; 62(3):325-31. PubMed ID: 638311 [TBL] [Abstract][Full Text] [Related]
11. The effect of estradiol on the alterations in monoamine-mediated behavioural responses induced by administration of electroconvulsive shocks or imipramine to female rats. Bhavsar VH; Dhumal VR; Kelkar VV Neuropharmacology; 1983 Jun; 22(6):751-6. PubMed ID: 6684220 [TBL] [Abstract][Full Text] [Related]
12. Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shock. Green AR; Sant K; Bowdler JM; Cowen PJ Neuropharmacology; 1982 Oct; 21(10):981-4. PubMed ID: 7145036 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of rat brain endogenous monoamine oxidase inhibitory activity (tribulin) by electroconvulsive shock. Bhattacharya SK; Banerjee PK; Glover V; Sandler M Neurosci Lett; 1991 Apr; 125(1):65-8. PubMed ID: 1857560 [TBL] [Abstract][Full Text] [Related]
14. Specificity of monoamine neurotoxins: rotational responses to dopaminergic agonists after unilateral 6-OHDA and 5,6-DHT lesions of the median forebrain bundle [proceedings]. Waddington JL; Crow TJ Br J Pharmacol; 1977 Mar; 59(3):465P-466P. PubMed ID: 300261 [No Abstract] [Full Text] [Related]
16. Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain--II. Behavioural studies. Lebrecht U; Nowak JZ Neuropharmacology; 1980 Nov; 19(11):1055-61. PubMed ID: 7442937 [No Abstract] [Full Text] [Related]
17. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour. Green AR; Youdim MB; Grahame-Smith DG Neuropharmacology; 1976 Mar; 15(3):173-9. PubMed ID: 132619 [No Abstract] [Full Text] [Related]
18. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine. Youdim MB Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597 [TBL] [Abstract][Full Text] [Related]
19. Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy. Costain DW; Green AR; Grahame-Smith DG Psychopharmacology (Berl); 1979 Mar; 61(2):167-70. PubMed ID: 108733 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological studies on serotonin-mediated behaviour. Green AR J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]